nodes	percent_of_prediction	percent_of_DWPC	metapath
Adinazolam—CYP2C19—prostate cancer	0.258	0.611	CbGaD
Adinazolam—CYP3A4—prostate cancer	0.164	0.389	CbGaD
Adinazolam—CYP2C19—Bicalutamide—prostate cancer	0.0581	0.126	CbGbCtD
Adinazolam—CYP2C19—Nilutamide—prostate cancer	0.0581	0.126	CbGbCtD
Adinazolam—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0535	0.116	CbGbCtD
Adinazolam—CYP2C19—Flutamide—prostate cancer	0.0482	0.105	CbGbCtD
Adinazolam—CYP3A4—Bicalutamide—prostate cancer	0.0281	0.061	CbGbCtD
Adinazolam—CYP3A4—Estramustine—prostate cancer	0.0261	0.0567	CbGbCtD
Adinazolam—CYP3A4—Flutamide—prostate cancer	0.0233	0.0506	CbGbCtD
Adinazolam—CYP3A4—Abiraterone—prostate cancer	0.0233	0.0506	CbGbCtD
Adinazolam—CYP2C19—Estradiol—prostate cancer	0.02	0.0434	CbGbCtD
Adinazolam—CYP3A4—Cabazitaxel—prostate cancer	0.0172	0.0374	CbGbCtD
Adinazolam—CYP2C19—Prednisone—prostate cancer	0.0172	0.0374	CbGbCtD
Adinazolam—CYP3A4—Estrone—prostate cancer	0.0168	0.0366	CbGbCtD
Adinazolam—CYP3A4—Ethinyl Estradiol—prostate cancer	0.015	0.0326	CbGbCtD
Adinazolam—CYP3A4—Conjugated Estrogens—prostate cancer	0.011	0.0239	CbGbCtD
Adinazolam—CYP3A4—Mitoxantrone—prostate cancer	0.01	0.0217	CbGbCtD
Adinazolam—CYP3A4—Estradiol—prostate cancer	0.00967	0.021	CbGbCtD
Adinazolam—CYP3A4—Prednisone—prostate cancer	0.00832	0.0181	CbGbCtD
Adinazolam—CYP3A4—Etoposide—prostate cancer	0.00631	0.0137	CbGbCtD
Adinazolam—CYP3A4—Docetaxel—prostate cancer	0.00578	0.0125	CbGbCtD
Adinazolam—CYP3A4—Doxorubicin—prostate cancer	0.00431	0.00935	CbGbCtD
Adinazolam—CYP2C19—urine—prostate cancer	0.00129	0.135	CbGeAlD
Adinazolam—GABRP—prostate gland—prostate cancer	0.000829	0.0862	CbGeAlD
Adinazolam—CYP3A4—urine—prostate cancer	0.000765	0.0796	CbGeAlD
Adinazolam—Oxazepam—UGT2B15—prostate cancer	0.000735	0.111	CrCbGaD
Adinazolam—Oxazepam—CYP3A43—prostate cancer	0.000637	0.0964	CrCbGaD
Adinazolam—GABRE—prostate gland—prostate cancer	0.000633	0.0658	CbGeAlD
Adinazolam—GABRP—urethra—prostate cancer	0.000555	0.0577	CbGeAlD
Adinazolam—GABRB3—prostate gland—prostate cancer	0.000536	0.0558	CbGeAlD
Adinazolam—GABRE—seminal vesicle—prostate cancer	0.000535	0.0557	CbGeAlD
Adinazolam—GABRG3—testis—prostate cancer	0.000527	0.0549	CbGeAlD
Adinazolam—GABRR1—testis—prostate cancer	0.000503	0.0523	CbGeAlD
Adinazolam—GABRD—testis—prostate cancer	0.000437	0.0454	CbGeAlD
Adinazolam—GABRE—urethra—prostate cancer	0.000424	0.0441	CbGeAlD
Adinazolam—GABRA5—testis—prostate cancer	0.000405	0.0422	CbGeAlD
Adinazolam—GABRR2—lymph node—prostate cancer	0.000378	0.0394	CbGeAlD
Adinazolam—GABRA3—testis—prostate cancer	0.000377	0.0393	CbGeAlD
Adinazolam—Clobazam—CYP2C18—prostate cancer	0.00034	0.0515	CrCbGaD
Adinazolam—GABRB2—testis—prostate cancer	0.000308	0.032	CbGeAlD
Adinazolam—GABRE—testis—prostate cancer	0.000279	0.029	CbGeAlD
Adinazolam—Clomipramine—GSTP1—prostate cancer	0.000238	0.036	CrCbGaD
Adinazolam—GABRB3—testis—prostate cancer	0.000236	0.0246	CbGeAlD
Adinazolam—Alprazolam—CYP3A5—prostate cancer	0.000224	0.034	CrCbGaD
Adinazolam—GABRA2—lymph node—prostate cancer	0.000204	0.0212	CbGeAlD
Adinazolam—GABRE—lymph node—prostate cancer	0.000202	0.021	CbGeAlD
Adinazolam—Diazepam—CYP2C18—prostate cancer	0.000199	0.0301	CrCbGaD
Adinazolam—Flunitrazepam—CYP2A6—prostate cancer	0.000199	0.0301	CrCbGaD
Adinazolam—Midazolam—SLC22A1—prostate cancer	0.000189	0.0287	CrCbGaD
Adinazolam—CYP3A4—renal system—prostate cancer	0.000187	0.0195	CbGeAlD
Adinazolam—Triazolam—CYP3A5—prostate cancer	0.000165	0.0249	CrCbGaD
Adinazolam—Oxazepam—CYP3A5—prostate cancer	0.00016	0.0242	CrCbGaD
Adinazolam—Flurazepam—CYP2A6—prostate cancer	0.00016	0.0242	CrCbGaD
Adinazolam—Midazolam—CYP3A5—prostate cancer	0.000153	0.0231	CrCbGaD
Adinazolam—Clobazam—CYP2C19—prostate cancer	0.000153	0.0231	CrCbGaD
Adinazolam—Chlorpromazine—SLC22A1—prostate cancer	0.000151	0.0228	CrCbGaD
Adinazolam—Quazepam—CYP2C19—prostate cancer	0.000148	0.0224	CrCbGaD
Adinazolam—Flunitrazepam—CYP2E1—prostate cancer	0.000141	0.0214	CrCbGaD
Adinazolam—Flunitrazepam—CYP2C19—prostate cancer	0.00014	0.0212	CrCbGaD
Adinazolam—Ketazolam—CYP3A4—prostate cancer	0.000137	0.0208	CrCbGaD
Adinazolam—Diazepam—CYP3A5—prostate cancer	0.000131	0.0198	CrCbGaD
Adinazolam—Nitrazepam—CYP2E1—prostate cancer	0.000127	0.0193	CrCbGaD
Adinazolam—Clomipramine—CYP2C19—prostate cancer	0.000121	0.0183	CrCbGaD
Adinazolam—Chlordiazepoxide—CYP3A4—prostate cancer	0.000115	0.0174	CrCbGaD
Adinazolam—Flurazepam—CYP2E1—prostate cancer	0.000113	0.0172	CrCbGaD
Adinazolam—Temazepam—CYP2C19—prostate cancer	0.000107	0.0162	CrCbGaD
Adinazolam—Clorazepate—CYP3A4—prostate cancer	0.000107	0.0162	CrCbGaD
Adinazolam—Midazolam—CYP2E1—prostate cancer	0.000105	0.0159	CrCbGaD
Adinazolam—Alprazolam—CYP3A4—prostate cancer	9.71e-05	0.0147	CrCbGaD
Adinazolam—Clobazam—CYP3A4—prostate cancer	9.71e-05	0.0147	CrCbGaD
Adinazolam—Quazepam—CYP3A4—prostate cancer	9.41e-05	0.0143	CrCbGaD
Adinazolam—Diazepam—CYP2E1—prostate cancer	9e-05	0.0136	CrCbGaD
Adinazolam—Diazepam—CYP2C19—prostate cancer	8.91e-05	0.0135	CrCbGaD
Adinazolam—Flunitrazepam—CYP3A4—prostate cancer	8.89e-05	0.0135	CrCbGaD
Adinazolam—Chlorpromazine—CYP2E1—prostate cancer	8.36e-05	0.0127	CrCbGaD
Adinazolam—Estazolam—CYP3A4—prostate cancer	8.31e-05	0.0126	CrCbGaD
Adinazolam—Nitrazepam—CYP3A4—prostate cancer	8.02e-05	0.0121	CrCbGaD
Adinazolam—Clomipramine—CYP3A4—prostate cancer	7.67e-05	0.0116	CrCbGaD
Adinazolam—Prazepam—CYP3A4—prostate cancer	7.65e-05	0.0116	CrCbGaD
Adinazolam—Flurazepam—CYP3A4—prostate cancer	7.13e-05	0.0108	CrCbGaD
Adinazolam—Triazolam—CYP3A4—prostate cancer	7.12e-05	0.0108	CrCbGaD
Adinazolam—Oxazepam—CYP3A4—prostate cancer	6.91e-05	0.0105	CrCbGaD
Adinazolam—Temazepam—CYP3A4—prostate cancer	6.82e-05	0.0103	CrCbGaD
Adinazolam—Midazolam—CYP3A4—prostate cancer	6.61e-05	0.01	CrCbGaD
Adinazolam—Diazepam—CYP3A4—prostate cancer	5.67e-05	0.00858	CrCbGaD
Adinazolam—Chlorpromazine—CYP3A4—prostate cancer	5.26e-05	0.00797	CrCbGaD
Adinazolam—GABRA2—Transmembrane transport of small molecules—PPARA—prostate cancer	1.99e-05	0.000196	CbGpPWpGaD
Adinazolam—GABRB3—Transmembrane transport of small molecules—PPARA—prostate cancer	1.98e-05	0.000195	CbGpPWpGaD
Adinazolam—CYP3A4—Biological oxidations—NCOA1—prostate cancer	1.98e-05	0.000195	CbGpPWpGaD
Adinazolam—GABRB1—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.98e-05	0.000195	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—UGT2B15—prostate cancer	1.96e-05	0.000193	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—GRHPR—prostate cancer	1.96e-05	0.000193	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—UGT2B17—prostate cancer	1.96e-05	0.000193	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—CKMT2—prostate cancer	1.96e-05	0.000193	CbGpPWpGaD
Adinazolam—CYP3A4—Biological oxidations—CYP19A1—prostate cancer	1.95e-05	0.000192	CbGpPWpGaD
Adinazolam—GABRG2—Transmembrane transport of small molecules—PPARA—prostate cancer	1.95e-05	0.000192	CbGpPWpGaD
Adinazolam—CYP3A4—Metapathway biotransformation—CYP19A1—prostate cancer	1.93e-05	0.00019	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—SULT2A1—prostate cancer	1.91e-05	0.000188	CbGpPWpGaD
Adinazolam—CYP3A4—Biological oxidations—RXRA—prostate cancer	1.88e-05	0.000186	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—MED12—prostate cancer	1.88e-05	0.000185	CbGpPWpGaD
Adinazolam—GABRA6—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.87e-05	0.000184	CbGpPWpGaD
Adinazolam—GABRA4—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.85e-05	0.000182	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—GSTM3—prostate cancer	1.84e-05	0.000181	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—SULT2B1—prostate cancer	1.84e-05	0.000181	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—RFK—prostate cancer	1.84e-05	0.000181	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—NAGLU—prostate cancer	1.84e-05	0.000181	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—PGAM2—prostate cancer	1.84e-05	0.000181	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—AOX1—prostate cancer	1.84e-05	0.000181	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—MBTPS1—prostate cancer	1.84e-05	0.000181	CbGpPWpGaD
Adinazolam—CYP3A4—Biological oxidations—COMT—prostate cancer	1.82e-05	0.000179	CbGpPWpGaD
Adinazolam—CYP3A4—Biological oxidations—GSTP1—prostate cancer	1.81e-05	0.000178	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—NCOA3—prostate cancer	1.8e-05	0.000177	CbGpPWpGaD
Adinazolam—CYP3A4—Metapathway biotransformation—COMT—prostate cancer	1.79e-05	0.000176	CbGpPWpGaD
Adinazolam—GABRA1—SIDS Susceptibility Pathways—IL6—prostate cancer	1.78e-05	0.000176	CbGpPWpGaD
Adinazolam—CYP3A4—Metapathway biotransformation—GSTP1—prostate cancer	1.78e-05	0.000175	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—CYP3A43—prostate cancer	1.74e-05	0.000172	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—AMACR—prostate cancer	1.74e-05	0.000172	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—NAT1—prostate cancer	1.74e-05	0.000172	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—SRD5A2—prostate cancer	1.74e-05	0.000172	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—DEGS1—prostate cancer	1.74e-05	0.000172	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—prostate cancer	1.72e-05	0.000169	CbGpPWpGaD
Adinazolam—GABRA1—Transmembrane transport of small molecules—PPARA—prostate cancer	1.7e-05	0.000168	CbGpPWpGaD
Adinazolam—GABRB2—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.69e-05	0.000166	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—HSD17B1—prostate cancer	1.66e-05	0.000164	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—prostate cancer	1.66e-05	0.000164	CbGpPWpGaD
Adinazolam—CYP3A4—Biological oxidations—GSTM1—prostate cancer	1.66e-05	0.000164	CbGpPWpGaD
Adinazolam—GABRA5—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.64e-05	0.000162	CbGpPWpGaD
Adinazolam—CYP3A4—Metapathway biotransformation—GSTM1—prostate cancer	1.64e-05	0.000161	CbGpPWpGaD
Adinazolam—GABRA3—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.61e-05	0.000159	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—prostate cancer	1.6e-05	0.000158	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—PRKACB—prostate cancer	1.59e-05	0.000157	CbGpPWpGaD
Adinazolam—GABRA2—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.58e-05	0.000156	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—CYP17A1—prostate cancer	1.58e-05	0.000155	CbGpPWpGaD
Adinazolam—CYP3A4—Biological oxidations—CYP1A1—prostate cancer	1.57e-05	0.000155	CbGpPWpGaD
Adinazolam—GABRB3—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.57e-05	0.000155	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—HAO1—prostate cancer	1.55e-05	0.000153	CbGpPWpGaD
Adinazolam—CYP3A4—Metapathway biotransformation—CYP1A1—prostate cancer	1.55e-05	0.000153	CbGpPWpGaD
Adinazolam—GABRG2—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.55e-05	0.000152	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—NCOA2—prostate cancer	1.5e-05	0.000148	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—B4GALT4—prostate cancer	1.48e-05	0.000146	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—HPGD—prostate cancer	1.48e-05	0.000146	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—TNFRSF21—prostate cancer	1.39e-05	0.000137	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—CYP7B1—prostate cancer	1.36e-05	0.000134	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—MTAP—prostate cancer	1.36e-05	0.000134	CbGpPWpGaD
Adinazolam—GABRA1—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.35e-05	0.000133	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	1.33e-05	0.000131	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—SULT1E1—prostate cancer	1.32e-05	0.00013	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—SRD5A1—prostate cancer	1.32e-05	0.00013	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	1.28e-05	0.000126	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—CBR1—prostate cancer	1.27e-05	0.000125	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—ADI1—prostate cancer	1.27e-05	0.000125	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—PSAT1—prostate cancer	1.27e-05	0.000125	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—CSAD—prostate cancer	1.27e-05	0.000125	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—TST—prostate cancer	1.27e-05	0.000125	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—GRHL1—prostate cancer	1.27e-05	0.000125	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	1.27e-05	0.000125	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—HSD17B3—prostate cancer	1.26e-05	0.000124	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—ACSL4—prostate cancer	1.26e-05	0.000124	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	1.25e-05	0.000123	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—ARG2—prostate cancer	1.21e-05	0.000119	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—UMPS—prostate cancer	1.21e-05	0.000119	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—PHGDH—prostate cancer	1.21e-05	0.000119	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	1.2e-05	0.000119	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—LDHB—prostate cancer	1.19e-05	0.000117	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—UGT2B15—prostate cancer	1.18e-05	0.000116	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—UGT2B17—prostate cancer	1.18e-05	0.000116	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—GRHPR—prostate cancer	1.18e-05	0.000116	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—CKMT2—prostate cancer	1.18e-05	0.000116	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—CYP3A5—prostate cancer	1.16e-05	0.000115	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—PDHA1—prostate cancer	1.12e-05	0.000111	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—GSTA3—prostate cancer	1.12e-05	0.000111	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—TCN2—prostate cancer	1.12e-05	0.000111	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—UCP3—prostate cancer	1.12e-05	0.000111	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—NAGLU—prostate cancer	1.11e-05	0.000109	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—GSTM3—prostate cancer	1.11e-05	0.000109	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—SULT2B1—prostate cancer	1.11e-05	0.000109	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—RFK—prostate cancer	1.11e-05	0.000109	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—AOX1—prostate cancer	1.11e-05	0.000109	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—MBTPS1—prostate cancer	1.11e-05	0.000109	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—PGAM2—prostate cancer	1.11e-05	0.000109	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—HSD3B1—prostate cancer	1.07e-05	0.000106	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—SLC22A3—prostate cancer	1.07e-05	0.000106	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—CYP3A43—prostate cancer	1.05e-05	0.000103	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—AMACR—prostate cancer	1.05e-05	0.000103	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—SRD5A2—prostate cancer	1.05e-05	0.000103	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—DEGS1—prostate cancer	1.05e-05	0.000103	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—NAT1—prostate cancer	1.05e-05	0.000103	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—LPL—prostate cancer	1.04e-05	0.000102	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—TBXAS1—prostate cancer	1.03e-05	0.000101	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—GSTA4—prostate cancer	1.03e-05	0.000101	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	1.01e-05	9.9e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—GSTA2—prostate cancer	1e-05	9.87e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—HSD17B1—prostate cancer	1e-05	9.86e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—ABCG5—prostate cancer	9.9e-06	9.75e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—SULT1A1—prostate cancer	9.9e-06	9.75e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—GSTA1—prostate cancer	9.67e-06	9.52e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—GSTO1—prostate cancer	9.56e-06	9.42e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—HSD3B2—prostate cancer	9.56e-06	9.42e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—NAT2—prostate cancer	9.56e-06	9.42e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	9.19e-06	9.05e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—PLCB2—prostate cancer	9.17e-06	9.03e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—LRP2—prostate cancer	9.17e-06	9.03e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—CYP2C18—prostate cancer	9.17e-06	9.03e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—P4HB—prostate cancer	8.99e-06	8.85e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—HPGD—prostate cancer	8.92e-06	8.79e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—B4GALT4—prostate cancer	8.92e-06	8.79e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—SLC22A1—prostate cancer	8.74e-06	8.61e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	8.64e-06	8.51e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—SULT2A1—prostate cancer	8.52e-06	8.39e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—TNFRSF21—prostate cancer	8.39e-06	8.26e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—MED12—prostate cancer	8.38e-06	8.26e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—GNG5—prostate cancer	8.32e-06	8.19e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—MTAP—prostate cancer	8.16e-06	8.04e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—CYP7B1—prostate cancer	8.16e-06	8.04e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—NCOA3—prostate cancer	8.01e-06	7.89e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—SULT1E1—prostate cancer	7.95e-06	7.83e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—SRD5A1—prostate cancer	7.95e-06	7.83e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	7.87e-06	7.75e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—HPGDS—prostate cancer	7.64e-06	7.53e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—HSD17B3—prostate cancer	7.59e-06	7.47e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—ACSL4—prostate cancer	7.59e-06	7.47e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—ACHE—prostate cancer	7.41e-06	7.3e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—GSTT1—prostate cancer	7.41e-06	7.3e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—CYP2A6—prostate cancer	7.33e-06	7.22e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	7.3e-06	7.19e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—ARG2—prostate cancer	7.27e-06	7.16e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—PHGDH—prostate cancer	7.27e-06	7.16e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—UMPS—prostate cancer	7.27e-06	7.16e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—LDHB—prostate cancer	7.13e-06	7.02e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—AKR1C3—prostate cancer	7.13e-06	7.02e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—PRKACB—prostate cancer	7.09e-06	6.98e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—CYP17A1—prostate cancer	7.02e-06	6.91e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—CYP3A5—prostate cancer	7e-06	6.89e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	6.92e-06	6.82e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—PDHA1—prostate cancer	6.76e-06	6.66e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—TCN2—prostate cancer	6.76e-06	6.66e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—UCP3—prostate cancer	6.76e-06	6.66e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—GSTA3—prostate cancer	6.76e-06	6.66e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—NCOA2—prostate cancer	6.69e-06	6.59e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—SLC22A3—prostate cancer	6.45e-06	6.35e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—HSD3B1—prostate cancer	6.45e-06	6.35e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—SLC5A5—prostate cancer	6.38e-06	6.28e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—CYP2E1—prostate cancer	6.23e-06	6.14e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—GSTA4—prostate cancer	6.18e-06	6.09e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—TBXAS1—prostate cancer	6.18e-06	6.09e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—NQO1—prostate cancer	6.16e-06	6.07e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—TH—prostate cancer	6.07e-06	5.98e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	6.03e-06	5.94e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—GSTA2—prostate cancer	6.03e-06	5.93e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—CYP3A4—prostate cancer	6.01e-06	5.92e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	5.98e-06	5.89e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—ABCG5—prostate cancer	5.95e-06	5.86e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—SULT1A1—prostate cancer	5.95e-06	5.86e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—CYP1B1—prostate cancer	5.91e-06	5.82e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—GSTA1—prostate cancer	5.81e-06	5.73e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—GSTO1—prostate cancer	5.75e-06	5.66e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—HSD3B2—prostate cancer	5.75e-06	5.66e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—NAT2—prostate cancer	5.75e-06	5.66e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—GGT1—prostate cancer	5.72e-06	5.63e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—NCOA1—prostate cancer	5.63e-06	5.55e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—CYP19A1—prostate cancer	5.55e-06	5.47e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—PLCB2—prostate cancer	5.51e-06	5.43e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—LRP2—prostate cancer	5.51e-06	5.43e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—CYP2C18—prostate cancer	5.51e-06	5.43e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—P4HB—prostate cancer	5.41e-06	5.32e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—RXRA—prostate cancer	5.36e-06	5.28e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—SLC22A1—prostate cancer	5.26e-06	5.18e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	5.21e-06	5.13e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—COMT—prostate cancer	5.16e-06	5.08e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—GSTP1—prostate cancer	5.14e-06	5.06e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—SULT2A1—prostate cancer	5.12e-06	5.05e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—ITPR1—prostate cancer	5.06e-06	4.98e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—MED12—prostate cancer	5.04e-06	4.96e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—GNG5—prostate cancer	5e-06	4.93e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	4.97e-06	4.9e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—NCOA3—prostate cancer	4.82e-06	4.74e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—TYMS—prostate cancer	4.78e-06	4.7e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—GSTM1—prostate cancer	4.72e-06	4.65e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—LPL—prostate cancer	4.63e-06	4.56e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—HPGDS—prostate cancer	4.6e-06	4.53e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—CYP2C19—prostate cancer	4.57e-06	4.5e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—CYP1A1—prostate cancer	4.48e-06	4.41e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—ACHE—prostate cancer	4.46e-06	4.39e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—GSTT1—prostate cancer	4.46e-06	4.39e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—ERCC2—prostate cancer	4.44e-06	4.37e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—CYP2A6—prostate cancer	4.41e-06	4.34e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—AKR1C3—prostate cancer	4.29e-06	4.22e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—PRKACB—prostate cancer	4.26e-06	4.2e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—CYP17A1—prostate cancer	4.22e-06	4.16e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—MTHFR—prostate cancer	4.17e-06	4.11e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—PPARA—prostate cancer	4.09e-06	4.03e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—NCOA2—prostate cancer	4.02e-06	3.96e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—CAV1—prostate cancer	3.85e-06	3.79e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—SLC5A5—prostate cancer	3.84e-06	3.78e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—CYP2E1—prostate cancer	3.75e-06	3.69e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—NQO1—prostate cancer	3.7e-06	3.65e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.68e-06	3.62e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—TH—prostate cancer	3.65e-06	3.6e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—CYP1B1—prostate cancer	3.55e-06	3.5e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—PIK3CG—prostate cancer	3.51e-06	3.45e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—GGT1—prostate cancer	3.44e-06	3.39e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—NCOA1—prostate cancer	3.39e-06	3.34e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—CYP19A1—prostate cancer	3.34e-06	3.29e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—INS—prostate cancer	3.32e-06	3.27e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—CREBBP—prostate cancer	3.25e-06	3.2e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—RXRA—prostate cancer	3.22e-06	3.17e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—COMT—prostate cancer	3.1e-06	3.06e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—GSTP1—prostate cancer	3.09e-06	3.04e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—PIK3CD—prostate cancer	3.08e-06	3.04e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—ITPR1—prostate cancer	3.04e-06	2.99e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—NOS3—prostate cancer	2.91e-06	2.87e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—TYMS—prostate cancer	2.87e-06	2.83e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—GSTM1—prostate cancer	2.84e-06	2.8e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—LPL—prostate cancer	2.79e-06	2.74e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—CYP1A1—prostate cancer	2.69e-06	2.65e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—PIK3CB—prostate cancer	2.69e-06	2.65e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—ERCC2—prostate cancer	2.67e-06	2.63e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—PTGS2—prostate cancer	2.66e-06	2.62e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—MTHFR—prostate cancer	2.51e-06	2.47e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—PPARA—prostate cancer	2.46e-06	2.42e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—PTEN—prostate cancer	2.32e-06	2.29e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—CAV1—prostate cancer	2.31e-06	2.28e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—EP300—prostate cancer	2.21e-06	2.18e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—PIK3CG—prostate cancer	2.11e-06	2.08e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—INS—prostate cancer	2e-06	1.97e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—CREBBP—prostate cancer	1.95e-06	1.93e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.85e-06	1.83e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—NOS3—prostate cancer	1.75e-06	1.72e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—PIK3CA—prostate cancer	1.64e-06	1.61e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.62e-06	1.59e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—PTGS2—prostate cancer	1.6e-06	1.58e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—PTEN—prostate cancer	1.4e-06	1.37e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—AKT1—prostate cancer	1.34e-06	1.32e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—EP300—prostate cancer	1.33e-06	1.31e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—PIK3CA—prostate cancer	9.85e-07	9.7e-06	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—AKT1—prostate cancer	8.05e-07	7.92e-06	CbGpPWpGaD
